Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
ONDANSETRON-AFT (AFT Pharmaceuticals Pty Ltd)
Product name
ONDANSETRON-AFT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
249 working days (255)
Active ingredients
ondansetron
Registration type
New generic medicine
Indication
ONDANSETRON-AFT (solution for injection) is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ONDANSETRON-AFT is also indicated for the prevention and treatment of post-operative nausea and vomiting.